DCGI nod to Bharat Biotech's Intranasal Covid booster dose for restricted use
Dcgi News Collection
-
-
DCGI grants EUA to 3 Covid vaccines for different age group of children
-
DCGI permits Bharat Biotech to conduct trials for intranasal booster dose
-
DCGI grants regular market approval for Covishield, Covaxin with conditions
-
Sun Pharma gets DCGI nod for Merck's anti-Covid pill in India
-
-
Covaxin gets DCGI nod for emergency use for children aged 12-18
-
DCGI nod to Phase III trials of two-dose Zydus vax
